With these new product wins, Rallis has broadened its CSM customer base especially among Japanese innovator agrochemical companies.
Rallis India Ltd, a leading agri-inputs company, grew its Custom Synthesis & Manufacturing (CSM) portfolio through commercialization of 3 new products in FY24. These new products span across the agrochemical value chain and include one each of Intermediates, Active Ingredients (AI) and Formulations. Two of these three products are being manufactured at Rallis India’s new manufacturing plants at Dahej. With these new product wins, Rallis has broadened its CSM customer base especially among Japanese innovator agrochemical companies.
Commenting on this development, Sanjiv Lal, MD & CEO of Rallis India Limited said, “This expansion of our CSM portfolio reflects our strategic commitment to more chemistry-led manufacturing underlying our recent investments at Dahej. These new product successes and customer acquisitions further affirm the enduring trust that Rallis India holds from a growing number of Japanese and other global agrochemical companies”.
S.Nagarajan, Chief Operating Officer of Rallis India Limited, added, “The commercialisation of these new products demonstrates our enhanced process development, scale-up and manufacturing capabilities to handle complex chemistries and next-gen sustainable formulations. It is also a testament to our ability to work closely and transparently with the customers to deliver high quality products at the right price while upholding our stringent EHS standards”.
Rallis remains committed to further expansion and scale-up of its product portfolio by strengthening its existing customer partnerships and building new ones with global agrochemical companies to advance the cause of sustainable agriculture.
